177 related articles for article (PubMed ID: 20110667)
1. Contrasting effects of steroids and mizoribine on macrophage activation and glomerular lesions in rat thy-1 mesangial proliferative glomerulonephritis.
Ikezumi Y; Suzuki T; Karasawa T; Hasegawa H; Kawachi H; Nikolic-Paterson DJ; Uchiyama M
Am J Nephrol; 2010; 31(3):273-82. PubMed ID: 20110667
[TBL] [Abstract][Full Text] [Related]
2. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic analysis of the glomerular and periglomerular mononuclear cell infiltrates in the Thy 1.1 model of glomerulonephritis.
Roy-Chaudhury P; Wu B; McDonald S; Haites NE; Simpson JG; Power DA
Lab Invest; 1995 May; 72(5):524-31. PubMed ID: 7745948
[TBL] [Abstract][Full Text] [Related]
4. Mizoribine in the treatment of pediatric-onset glomerular disease.
Tanaka H; Tsuruga K; Imaizumi T
World J Pediatr; 2015 May; 11(2):108-12. PubMed ID: 25754750
[TBL] [Abstract][Full Text] [Related]
5. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
[TBL] [Abstract][Full Text] [Related]
6. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
7. Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model).
Jefferson JA; Johnson RJ
J Nephrol; 1999; 12(5):297-307. PubMed ID: 10630692
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of macrophage activation in anti-Thy-1.1 nephritis.
Minto AW; Erwig LP; Rees AJ
Am J Pathol; 2003 Nov; 163(5):2033-41. PubMed ID: 14578202
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
12. Mizoribine suppresses proliferation of rat glomerular epithelial cells in culture and inhibits increase of monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 stimulated by thrombin.
Yamabe H; Shimada M; Murakami R; Fujita T; Shimaya Y; Nakamura N
Biol Pharm Bull; 2012; 35(5):705-8. PubMed ID: 22687405
[TBL] [Abstract][Full Text] [Related]
13. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
[TBL] [Abstract][Full Text] [Related]
14. Single application of low-dose mycophenolate mofetil-OX7-immunoliposomes ameliorates experimental mesangial proliferative glomerulonephritis.
Suana AJ; Tuffin G; Frey BM; Knudsen L; Mühlfeld C; Rödder S; Marti HP
J Pharmacol Exp Ther; 2011 May; 337(2):411-22. PubMed ID: 21349934
[TBL] [Abstract][Full Text] [Related]
15. Expression of macrophage migration inhibitory factor in human glomerulonephritis.
Lan HY; Yang N; Nikolic-Paterson DJ; Yu XQ; Mu W; Isbel NM; Metz CN; Bucala R; Atkins RC
Kidney Int; 2000 Feb; 57(2):499-509. PubMed ID: 10652026
[TBL] [Abstract][Full Text] [Related]
16. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis.
Ikezumi Y; Suzuki T; Hayafuji S; Okubo S; Nikolic-Paterson DJ; Kawachi H; Shimizu F; Uchiyama M
Nephrol Dial Transplant; 2005 Dec; 20(12):2704-13. PubMed ID: 16169862
[TBL] [Abstract][Full Text] [Related]
17. Membranoproliferative glomerulonephritis related to a streptococcal infection in a girl with IgA deficiency: a case report.
Sugimoto K; Enya T; Miyazaki K; Miyazawa T; Takemura T; Okada M
BMC Nephrol; 2020 Feb; 21(1):68. PubMed ID: 32103732
[TBL] [Abstract][Full Text] [Related]
18. An anti-CD5 monoclonal antibody ameliorates proteinuria and glomerular lesions in rat mesangioproliferative glomerulonephritis.
Ikezumi Y; Kawachi H; Toyabe S; Uchiyama M; Shimizu F
Kidney Int; 2000 Jul; 58(1):100-14. PubMed ID: 10886554
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C β inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
Tokuyama H; Kim S; Zhang Y; Langham RG; Cox AJ; Gow RM; Kelly DJ; Gilbert RE
Nephrology (Carlton); 2011 Sep; 16(7):649-55. PubMed ID: 21575103
[TBL] [Abstract][Full Text] [Related]
20. Effects of leukocytosis and macrophage activation on anti-Thy 1.1 glomerulonephritis in the rat.
Futamura A; Izumino K; Sugawara H; Nakagawa Y; Inoue H; Takata M
Scand J Urol Nephrol; 2002; 36(6):435-42. PubMed ID: 12623508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
